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Abstract
Introduction:  The causes and management of acute urine retention (AUR) and chronic urine retention
(CUR) are different and varied in both gender and age. Urine retention has been well studied among males
worldwide, while data on urine retention among women are sparse. This study aimed at determining the
causes and management of AUR and CUR among adults at the Komfo Anokye Teaching Hospital (KATH),
Kumasi, Ghana.
Subjects  and  methods:  A prospective study was conducted during 8 months period. The study was carried
out at the Urology and Accident and Emergency Units of KATH. A complete work-up to establish the cause
of urine retention preceded data collection. The subject’s demographic data, causes and management of
urine retention with outcomes were recorded on data sheet. Data was analyzed using Stata version 12.0.
Results: Two hundred and six subjects were enrolled in the study. There were 198 men and 8 women with
mean ages of 62.8 ±  16.8 and 55.4 ±  18.4 years respectively. The prevalence of AUR and CUR in the
population were 172 (83.5%) and 34 (16.5%) respectively. Among the males 169 (85.4%) presented with
AUR while 29 (14.6%) presented with CUR. The causes of AUR or CUR in men were: benign prostatic
enlargement (BPE) 115 (58.1%), urethral stricture 29 (14.7%), carcinoma of the prostate 26 (13.1%),
traumatic urethral injury 26 (13.1%) and others 1%. AUR was found in 3 (37.5%) and CUR in 5 (62.5%)
of the women studied. Two women each had bladder carcinoma and neurogenic bladder respectively.
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One each of utero-vaginal prolapse, bladder stones, urethral tumour and urethral trauma respectively
were also found. Urinary tract infection occurred in 20 (9.7%) and renal insufficiency in 32 (16.5.0%)
of respondents. The mean volume of urine drained on catheterization was 800.0 ±  161.7 ml.
The immediate treatment was by urethral catheterization in 146 (70.9%) and suprapubic cystostomy in 60
(29.1%). The definitive treatment for the underlying causes of urine retention was varied.
Conclusions:  Acute and chronic urine retention is not uncommon, but credible baseline data on this con-
dition is nonexistent at KATH, Kumasi. Urine retention found among the participants was mainly AUR.
Men were the most affected with benign prostatic enlargement, being the leading cause. Among women,
acute or chronic urine retention was caused mainly by bladder cancer and neurogenic bladder. Initial and
definitive management were varied between causes, gender and age.
© 2015 Pan African Urological Surgeons’ Association. Production and hosting by Elsevier B.V. All rights reserved.
Introduction
Urinary retention is a common urologic emergency. It may have
various causes which differ depending on gender and age. Age is an
important risk factor for developing acute urinary retention (AUR).
One in 10 men in their seventies and a third of all men in their
eighties may be affected by this condition [1]. AUR is associated
with a sudden and often painful inability to pass urine despite blad-
der fullness and requires intervention to relieve the symptoms [2,3].
Chronic urinary retention (CUR) is a painless retention associated
with significant amounts of post-void residual urine [4–6]. AUR is
associated with a significantly impaired quality of life, stigmatiza-
tion and a substantial socioeconomic burden [7–11].
Definitive management of urinary retention depends on the under-
lying cause and may be medical or surgical. Immediate treatment
of AUR consists of bladder drainage by either passing a urethral
catheter or performing suprapubic cystostomy [12–14]. Treatment
of CUR is more complex, and catheterization is less urgent because
the condition is painless. Catheterization is indicated, when there
is an abnormal renal function or when the patient has lower uri-
nary tract symptoms with a poor detrusor function on urodynamic
studies.
Prospective studies on acute and chronic urinary retention are sparse
in Ghana, and little is known about the prevalence of this condition
in Kumasi. In view of this, there was the need to generate credible
baseline data in the area of acute and chronic urinary retention. Our
study therefore aimed at determining the causes and management
of AUR and CUR in adults at the Komfo Anokye Teaching Hospital
(KATH), Kumasi, Ghana.
Subjects  and  methods
A prospective hospital-based study was conducted at the Urology
and Accident and Emergency Units of KATH over an 8-month
period from April 1st to November 30th, 2012. It included 198 men
and 8 women with a mean age of 62.8 ±  16.8 (range 19–99) and
55.4 ±  18.4 (range 27–83) years, respectively. The male-to-female
ratio was 25:1. 172 (83.5%) patients presented with AUR, 169 of
them were men. Of the 34 (16.5%) patients presenting with CUR,
29 were men. A complete work-up to establish the cause of uri-
nary retention in each patient preceded data collection. The patients’
demographic data, the causes and the management of urinary reten-
tion, as well as the outcomes were recorded on a data sheet. The
data were analyzed using Stata version 12.0.
Results
The causes of AUR and CUR are illustrated in Fig. 1. The median
prostate volume measured on transrectal ultrasound was 86.7 ml
(interquartile range 61–132). The corresponding data on urethral
stricture-related risk factors in men presenting with urinary retention
are shown in Table 1.
The 34 patients (16.5%) with CUR had renal insufficiency which
was confirmed by elevated serum creatinine levels. Renal ultrasound
scan revealed hydronephrosis in 4.4% (n  = 9) of the total popula-
tion. The mean residual urine volume was 800.0 ±  161.7 ml (range
310–1650).
Urinary tract infection found in 20 (9.7%) patients with urinary
retention was mainly due to Escherichia  coli  (n  = 11, 55.0%), Kleb-
siella  species (n  = 9, 45.0%) and mixed bacterial growth (n  = 3,
15.0%).
AUR was found in 3 (37.5%) and CUR in 5 (62.5%) of the 8 female
patients studied. Two each had bladder carcinoma and neurogenic
underactive bladder. Utero-vaginal prolapse, bladder stones, ure-
thral tumour and urethral trauma were found in one female patient
each.
Treatment  of  AUR  in  men
The initial treatment for patients presenting with urinary reten-
tion consisted of bladder drainage. 146 (70.9%) patients received a
Table  1  Urethra stricture-related risk factors in patients presenting
with urinary retention (n  = 55).
Variable Total (%)
Traumatic urethral injury 26 (47.3%)
Idiopathic strictures 16 (29.1%)
Gonococcal urethral strictures 13 (23.6%)
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Figure  1  Causes of acute and chronic urinary retention in men. Note: The mean age of patients presenting with BPE, urethral stricture and prostate
cancer was 69.2 ±  10.3, 47.3 ±  18.9 and 72.3 ±  11.9 years, respectively.
urethral catheter, while suprapubic cystostomy was performed in 60
(29.1%).
Various delayed treatment modalities were instituted. The treatment
modalities used in the 115 men with AUR due to BPE are listed
in Table 2. A trial of micturition without catheter (TWOC) was
preceded by treatment with alpha-adrenergic blockers for 7 days.
The patients with prostate carcinoma presented with advanced dis-
ease and were offered androgen deprivation therapy. Bilateral total
orchidectomy (surgical castration) was performed in 17 (65.0%),
whereas medical castration was instituted in 9 (35.0%).
Of those diagnosed with urethral strictures, urethral dilatation was
performed in 28 (50.9%), urethroplasty in 26 (47.3%) and otis inter-
nal urethrotomy in 1 (1.8%).
Open cystolithotomy and circumcision were performed in the
patients with bladder calculi and paraphimosis, respectively.
Treatment  of  urinary  retention  in  female  patients
Various treatment modalities were used for definitive treatment of
women with acute or chronic urine retention. Radiotherapy was
the treatment of choice for the two women with advanced blad-
der carcinoma and one with advanced urethral carcinoma. The
Table  2  Treatment of men with benign prostatic enlargement
(n = 115).
Variable Total (%)
Attempt at TWOC was preceded by
administration of alpha-adrenergic
blockers for 7 days
49 (42.6%)
TURP after failed TWOC 1 (0.9%)
Open simple prostatectomy after
failed TWOC
20 (17.4%)
Refractory urinary retention due to
BPE with catheter in situ awaiting
surgery
45 (39.1%)
woman with a utero-vaginal prolapse was subjected to total vaginal
hysterectomy with pelvic floor repair. A bladder calculus was
removed by open cystolithotomy in one woman, while immediate
urethral repair was done for the patient with urethral trauma follow-
ing an impalement injury. Two women with neurogenic underactive
bladder were instructed to do clean intermittent self-catheterization.
Discussion
The reason for carrying out this study was the fact that, despite
the worldwide interest in the subject, there exists only a limited
amount of data with respect to the prevalence, causes and common
management of acute and chronic urinary retention at the KATH,
Kumasi.
Age is an important risk factor for developing AUR or CUR. The
mean age and underlying causes of AUR or CUR differ among the
various studies in the literature. Similarly, this study revealed a dif-
ferent mean age for BPE, urethral stricture and prostate carcinoma.
Ten percent of men in their seventies and one third of men in their
eighties are likely to develop AUR as reported by Jacobsen et al.
[1]. In West Africa, researchers in this field report the mean age of
patients presenting with AUR to be between 57.5 and 69.5 years
[15–17].
In Europe, the prevalence of AUR has been reported to be 44–52.3%
[14,18]. In the present study, the prevalence of AUR was found to be
83.5%, while CUR accounted for 16.5%. In view of the lack of an
international consensus on the definition of CUR, most prospective
studies excluded patients with CUR because of the difficulty asso-
ciated with the design of the study and the interpretation of results,
and the possibility of associated complications and the anticipation
of an adverse outcome [19].
Causes  of  AUR  in  male  patients
Across Africa, there are ongoing changes in life expectancy. Accord-
ing to the Ghana Statistical Service (GSS), the population trends
among Ghanaians indicate that the ageing of the population will
continue in the 21st century. The GSS revealed that by the year
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2010 the population of the elderly had increased to more than
seven-fold since the 1960 census. The GSS 2010 Population and
Housing Census Report noted an increasing proportion of the pop-
ulation surviving up to 60 years and beyond [20]. An association
between this rise in the proportion of the ageing population and an
increase in the number of patients with urinary retention may be
assumed.
BPE is the leading cause of AUR among men worldwide, accounting
for some 65% [14,18,21]. According to Ikuerowo et al. in Nigeria
the top two causes of AUR among adult males in the West African
sub region were BPE (64%) and urethral trauma in descending order
[17]. Likewise, according to a study carried out in Accra, Ghana,
the commonest causes of AUR in males were BPE, urethral rup-
ture, urethral stricture, and carcinoma of the prostate (in descending
order) [15]. This complies with the results of our study where BPE
was also found to be the leading cause of AUR.
Known risk factors for developing urethral stricture include
traumatic urethral catheterization and instrumentation, pelvic
fracture-related posterior urethral injury, straddle injury involving
the bulbar urethra and poorly treated sexually transmitted urethral
infections. But there are also urethral strictures of unknown cause.
In the developed world, traumatic urethral injury has been recorded
as the leading cause of urethral stricture in the long term [22,23],
which may partly be due to the frequent use of urethral catheter-
ization and associated traumatic urethral injuries, as well as to
the increase in road traffic accidents and their attendant associ-
ation with pelvic fracture-related urethral injuries. In our study,
we found traumatic urethral injuries to be the leading cause of
urinary retention among the 55 subjects with urethral stricture-
related risk factors for developing urinary retention. Recent reports
from the West African sub region suggest post-gonococcal and
catheter-related urethritis to be the main causes of urethral stricture
[24,25].
Carcinoma of the prostate (CaP) is fairly common among older
men and may result in AUR as the disease progresses. Yeboah et al.
reported that the prevalence of CaP was between 2.9 and 6.3% in
their work on changing patterns of causes of AUR in Ghana [15].
European and American data showed the prevalence of CaP to be
between 7.0 and 13.3% in patients with AUR [26,27]. It can therefore
be said that prostate carcinoma is a well-known and important cause
of AUR.
In this study, the diagnosis of CaP was based on histology with
13.1% of the men diagnosed with the disease presenting with uri-
nary retention. This rate is comparable to the earlier findings by
Moul et al. and was a result of our strict adherence to the protocol
for screening and diagnosis of CaP. All our patients whose digi-
tal rectal examination results were suggestive of CaP and whose
prostate specific antigen (PSA) levels were elevated were subjected
to further evaluation. Transrectal ultrasound-guided prostate biop-
sies were done for histological confirmation of the diagnosis. This
appears to be the standard practice for CaP and is supported by
various scientific authors [28–32].
Other causes of AUR among men in our study were bladder cal-
culi and paraphimosis. In the literature, bladder calculi have been
reported to be a cause of AUR in 0.2–2% of cases [18,33,34]. In our
study, bladder calculi were the cause of AUR in 0.5% of the male
patients, which falls within the range quoted in the literature.
Investigation  modalities  used  in  male  patients
Blood urea, serum creatinine and electrolytes are usually checked to
rule out an impaired renal function, especially in patients with high
pressure chronic renal failure. Recent American Urology Associa-
tion (AUA) guidelines do not recommend routine serum creatinine
measurement in the standard patient with BPE [35,36]. However,
for those with complications of BPE such as CUR there is the need
to establish renal function, because they may be at risk of devel-
oping renal insufficiency. It was shown to be cost effective when
additional investigations such as serum creatinine and upper urinary
tract imaging were carried out for suspected renal impairment.
Misdiagnosis of underlying renal impairment may be associated
with additional costs and health detriments that are likely to out-
weigh the costs of these tests [37]. In this present study, elevated
serum creatinine levels were found in 16.5% of the patients. Upper
urinary tract ultrasonography revealed hydronephrosis in 4.4% of
the cases. Patients with elevated serum creatinine did not have
immediate definitive surgical treatment for the underlying cause of
urinary retention until renal function had returned to normal. In the
short term, continuous bladder drainage was instituted with follow-
up serum creatinine measurements to assess renal function. Once
renal function had returned to normal, the catheter was spigotted
for the purpose of bladder training. Definitive surgical intervention
was then planned. Some of our patients (about 10%) with urinary
retention also had urinary tract infection with the major causative
organism being Escherichia  coli, followed by Klebsiella  spp.; we
suspect this might have been catheter-induced. In an earlier study
from KATH, Gyasi-Sarpong et al. established that bacterial urinary
tract infection among males with lower urinary tract obstruction was
mainly due to Escherichia  coli  [38].
Treatment  of  AUR  in  male  patients
The immediate treatment of urinary retention consisted of urethral
catheterization or suprapubic cystostomy. In this study, urethral
catheterization was the commonest modality used. Seventy-one per-
cent of our patients had urethral catheterization, because it was a
more familiar method, quick and easy to perform. Also Allardice
and Webb successfully passed urethral catheters in the majority of
their patients who presented with AUR [39,40]. In the remaining
patients we performed suprapubic cystostomy to relieve urinary
retention when urethral catheterization failed. This procedure was
usually performed by the emergency physician, the urology resi-
dent in training or by a urologist. There was no other strategy than
urethral catheterization or suprapubic cystostomy to relieve AUR in
this study. This is consistent with recommendations from the AUA
and the National Clinical Guideline Centre of the United Kingdom
[35,37].
Delayed treatment of AUR was varied. Both alpha blockers and
transurethral resection of the prostate (TURP) are clinically effec-
tive and cost effective treatment options for patients with BPE [41].
Various authors have demonstrated the cost effectiveness of the use
of alpha blockers followed by TWOC in patients with AUR, without
the need for re-catheterization [42–47]. In the present study, satis-
factory TWOC in the short term was found in 43% of those patients
in whom AUR was caused by BPE. In this group alpha-adrenergic
blockers were administered prior to the procedure, which may
have accounted for satisfactory voiding. Tamsulosin was the main
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medication administered to the patients in this study. It was used
in about 43.0% of the cases with AUR secondary to BPE. The
remaining patients who failed TWOC were discharged home with
either a urethral or suprapubic catheter in situ. They were followed
up for at least 2 months before definitive treatment was adminis-
tered. During this waiting period, they were seen at regular intervals
to ensure that they remained healthy and did not have any infection
connected with the catheter left in situ. The median prostate volume
of our patients was about 87 ml. Since larger prostates are less likely
to benefit from TWOC [43,44], a substantial number of our patients
were expected to fail primary TWOC or to eventually go into reten-
tion again. Such patients may require immediate re-catheterization,
later followed by surgery.
This study was limited with regard to long-term follow up and deter-
mination of the outcome of TWOC of the remaining 57.0% of the
patients.
Some authors suggested that patients above the age of 80 with a
mean catheterized residual urine volume greater than 900 ml are at
a high risk of treatment failure using TWOC [43,48,49]. In our study,
the mean catheterized residual urine volume was 800 ±  167 ml. This
could account for some of the failed TWOC.
TURP is the gold standard treatment for BPE with complications.
It is both clinically and cost effective [41,50]. Only one patient in
our study was subjected to TURP. This was due to the fact that
endoscopic services were not yet available at our institution at the
time of this study.
Urologists practicing under similar circumstances in Africa, where
resources are limited, may be unable to offer TURP which is a
well-known clinical and cost effective treatment option for BPE
in developed countries. Definitive treatment of our patients with
AUR/CUR due to BPE was performed via open surgery in 17%
of the cases. This could only be done after 60 days because of
the large number of patients and the lack of theatre space. Open
transvesical prostatectomy was suitable not only because of the lack
of endoscopic equipment, but also because of the large prostates
these patients presented with.
The remaining patients in this study are awaiting definitive surgery.
None of the patients was subjected to emergency prostatectomy
during the study period.
Practicing urologists are requested to be familiar with various
surgical techniques to deal with urethral strictures, as not every
technique is appropriate in all situations [51,52]. In hospitals located
in resource-endowed areas, minimally invasive techniques such as
dilatation and optical internal urethrotomy are more commonly
practised treatment options for urethral strictures than open ure-
throplasty [53,54]. However, many patients may require potentially
curative open surgical repair because of the high recurrence rate of
dilatation and optical urethrotomy [53]. Open surgical repair of ure-
thral strictures is considered to be more cost effective than repeated
urethrotomy [55]. Following advances in urethral surgery and the
excellent success rates of urethroplasty, reconstructive specialists
now favour open surgical treatment over endoscopic treatment of
most strictures [51,52,56–58].
In the present study, urethral dilatation was the procedure of choice
in over half (51%) of the patients in whom AUR was due to urethral
strictures. In the working environment of the author, where patients
have to queue for several months to have their turn for urethroplasty,
it was prudent to improve their quality of life with repeated dilatation
so that they could return to work early. Mensah et al. who worked
under similar circumstances lacking operating space used urethral
dilatation as an option in 44% of their patients [25].
In the present study, internal urethrotomy was performed in only one
patient (2.0%) of those with urethral strictures, which is due to the
fact that the centre lacked endoscopic equipment – a basic require-
ment for successful visual urethrotomy. The remaining patients
(47.0%) were subjected to urethroplasty. These findings suggest a
drift towards open surgical reconstruction of urethral stricture dis-
ease in our centre in contrast to the well-endowed centres of the
world, where endoscopic treatment is preferred.
Our patients with urinary retention due to CaP presented with
advanced disease. As a result, androgen deprivation therapy was
instituted (mainly bilateral total orchidectomy). Other uncommon
causes of AUR or CUR encountered in the course of the study (neu-
rogenic bladder, urethral tumour, phimosis and paraphimosis) were
managed appropriately as per our hospital’s protocol.
Treatment  of  CUR  in  male  patients
CUR is a painless retention of urine associated with a significant
post-void residual urine (PVR) volume [5]. Abrams et al. assigned
an arbitrary figure of 300 ml of residual urine after voiding as the
minimum volume required for the definition of CUR [59]. Some
investigators defined CUR as PVR urine of more than 400 ml [60],
or a post-void volume of 100–500 ml [61]; others have not given it
a definite volume [62]. George et al. defined high-pressure CUR
as raised intrinsic detrusor pressure during the filling phase of
micturition [63] with an intravesical pressure above 25 cm H2O,
leading to a bladder volume of >800 ml and often accompanied by
hydronephrosis [64–66]. Over time this leads to renal failure with
associated elevated serum creatinine. Low pressure chronic reten-
tion refers to large-volume retention in a very compliant bladder
with no hydronephrosis or renal failure. Usually, both the detrusor
pressure and flow rates are low [59,65]. In the present study, CUR
was found in about 17% of the patients. These patients had renal
insufficiency confirmed by the presence of elevated serum creati-
nine levels. Renal ultrasound scan also revealed hydronephrosis in
about 4% of the total population investigated. This last group of
patients had catheters connected to a urine bag for continuous blad-
der drainage until renal function returned to normal. The mean PVR
urine volume in these patients was 800.0 ±  161.7 ml.
Over three decades ago, Young and Mitchell reported that the mean
volume of urine withdrawn after catheterization in patients with
CUR was at least 800 ml [66]. In our work no urodynamic stud-
ies were done for this category of patients, and they are awaiting
definitive treatment after relief of CUR.
Treatment  of  urinary  retention  in  female  patients
The incidence of urinary retention in women is not well docu-
mented in the world literature. Female urinary retention is more
frequently described in small case series/reports with unusual
causes. Many cases of AUR are transient with no apparent cause,
which renders the management of these patients more chal-
lenging. The incidence of AUR in women is estimated to be
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7/100,000 persons [67]. AUR was found in 37.5% of the women in
the present study, while 62.5% presented with CUR. Medical prac-
titioners use various treatment modalities for women with urinary
retention. As such, treatment outcomes are more difficult to predict
when compared to male patients [68]. In women, immediate man-
agement of AUR requires immediate bladder decompression with
urethral catheterization, either with indwelling catheters or inter-
mittent catheterization [69,70]. In this series, the majority of the
female patients presented with bladder cancer and neurogenic blad-
der. Both patients with bladder carcinoma presented with advanced
disease, and they were managed with urethral catheterization and
manual evacuation of blood clots. Each of these patients was then
hemodynamically stabilized prior to taking tissue samples for his-
tological confirmation of the clinical diagnosis. Both were referred
for radiotherapy. Hysterectomy with McCall’s culdoplasty and ante-
rior vaginal colporrhaphy was performed by the gynaecologist for
the patient with utero-vaginal prolapse. The patient with blad-
der stones was successfully treated with open cystolithotomy. The
woman with a urethral tumour was offered radiotherapy when the
histology results revealed squamous cell carcinoma. Oncological
treatment was still ongoing for these cancer patients at the oncol-
ogy unit at KATH during the period of this present study. The
pelvic fracture-related urethral trauma was repaired primarily. The
two women with neurogenic underactive bladder were instructed to
do clean intermittent self-catheterization while awaiting definitive
treatment.
Conclusion
Acute and chronic urinary retention is not uncommon, but there are
no credible baseline data on this condition at KATH, Kumasi. The
type of urinary retention encountered in this study was mainly acute
urinary retention. Men were affected more frequently, with benign
prostatic enlargement being the leading cause. In the female patients,
acute or chronic urinary retention was mainly caused by bladder
cancer and neurogenic bladder. Initial and definitive management
varied, depending on the causes, gender and age.
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